| [1] |
Jemal A, Siegel R, Ward E, et al.Cancer statistics, 2007.CA Caner J Clin, 2007, 57(1):43-66.
|
| [2] |
Lee JH, Rosen EL, Mankoff DA.The role of radiotracer imaging in the diagnosis and management of patients with breast cancer:part1-overview, detection, and staging.J Nucl Med, 2009, 50(4):569-581.
|
| [3] |
赵亚平, 周世英, 刘荣波.等.乳腺X线片中成簇样微小钙化对乳腺癌的诊断价值.临床放射学杂志, 2001, 20(1):7-10.
|
| [4] |
汪敏, 彭绩, 许奕华, 等.超声检查、乳房X线摄影术在乳腺癌筛查和早期诊断中作用的Meta分析.疾病控制杂志, 2006, 10(1):33-34.
|
| [5] |
Abe N, Schmidt RA, Sennett CA, et al.US-guided core needle biopsy of axillary lymph nodes in patients with breast cancer:why and how to do it.Radiographics, 2007, 27(suppl 1):S91-S99.
|
| [6] |
陈林丽, 赵建农, 郭大静, 等.1H-MRS联合DCE-MRI在乳腺痛中的应用价值.中国医学计算机成像杂志, 2008, 14(2):106-110.
|
| [7] |
Mankoff DA, Dunnwald LK, Gralow JR, et al.[Tc-99m]-sestamibi uptake and washout in locally advanced breast cancer are correlated with tumor blood flow.Nucl Med Biol, 2002, 29(7):719-727.
|
| [8] |
Liberman M, Sampalis F, Mulder DS, et al.Breast cancer diagnosis by scintimammography:a meta-analysis and review of the literature.Breast Cancer Res Treat, 2003, 80(1):115-126.
|
| [9] |
Brem RF, Fishman M, Rapelyea JA.Detection of ductal carcinoma in situ with mammography, breast specific gamma imaging, and magnetic resonance imaging, a comparative study.Acad Radiol,2007, 14(8):945-950.
|
| [10] |
Brem RF, Floerkc AC, Rapelyea JA, et al.Breast-specific gamma imaging as an adjunct imaging modality for the diagnosis of breast cancer.Radiology, 2008, 247(3):651-657.
|
| [11] |
Longer I, Guller U, Berclaz G, et al.Mobidity of sentinel lymphnode biopsy (SLN) alone versus SLN and completion axillary lymph node dessection after breast cancer surgery:a prospective Swiss multicenter study on 659 patients.Ann Surg, 2007, 245(3):452-461.
|
| [12] |
李囡, 林保和, 欧阳涛, 等.467例乳腺癌患者99Tcm-利妥昔单抗前哨淋巴结显像结果分析.中华核医学杂志, 2009, 29(1):3-7.
|
| [13] |
周敏, 章英剑, 程竞仪.内乳前哨淋巴结99Tcm-硫胶体显像影响因素分析.中华核医学杂志, 2009, 29(1):8-11.
|
| [14] |
Kumar R, Chauhan A, Zhuang H, et al.Clinicopathologic factors associated with false negative FDG-PET in primary breast cancer.Breast Cancer Res Treat, 2006, 98(3):267-274.
|
| [15] |
Rosen EL, Eubank WB, Mankoff DA.FDG PET, PET/CT, and breast cancer imaging.Radiographics, 2007, 27(suppl 1):S215-S229.
|
| [16] |
Raylman RR, Majewski S, Smith MF, et al.The positron emission mammography/tomography breast imaging and biopsy system(PEM/PET):design, construction and phantom-based measurem-ents.Phys Med Biol, 2008, 53(3):637-653.
|
| [17] |
Wahl RL, Siegel BA, Coleman RE, et al.Prospective multicenter study of axillary nodal staging by positron emission tomography in breast cancer:a report of the staging breast cancer with PET study group.J Clin Oncl, 2004, 22(2):277-285.
|
| [18] |
Grant FD, Fahey FH, Packard AB, et al.Skeletal PET with 18F-fluoride:applying new technology to an old traccr.J Nucl Med,2008, 49(1):68-78.
|
| [19] |
Fogelman I, Cook G, Isreal O, et al.Positron emission tomography and bone metastases.Semin Nucl Med, 2005, 35(2):135-142.
|